Home › NDC Lookup › Ingredients › Omeprazole › 69230-0318-35
Omeprazole 20 mg Tablet, Delayed Release, 14-count — NDC 69230-0318-35 package photo

Omeprazole 20 mg Tablet, Delayed Release, 14-count

by Camber Consumer Care Inc · 1 BOTTLE in 1 CARTON (69230-318-35) / 14 TABLET, DELAYED RELEASE in 1 BOTTLE
NDC 69230-0318-35
🏷️ FDA NDC (as labeled) 69230-318-35 billing pads the product segment with a zero
This package
Contains14-count Cost per ea$0.4731 NADAC Per package$6.62 / 14 tablets Pack sizes8 compare ↓
Also priced by: Medicaid pays $0.6190/unit — full pricing hub ↓
Also comes in: 14 tablets 69230-0318-32 14 tablets 69230-0318-33 14 tablets 69230-0318-34 14 tablets 69230-0318-36 14 tablets 69230-0318-37 500 tablets 69230-0318-05 1000 tablets 69230-0318-10
OTC Generic On market Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

⚠️
Other active recalls for Omeprazole (different manufacturers) — 1 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Jun 30, 2025 — Presence of foreign tablets/capsules: presence of foreign Divalproex Sodium Extended-Release 250mg tablet in a bottle of omeprazole capsules. (Dr. Reddy's Laboratories, Inc.) · FDA recall D-0525-2025
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

🆔 Identity & classification

FDA NDC (as labeled) 69230-318-35
Product NDC 69230-318
11-digit billing NDC 69230031835
NCPDP billing unit EA — each (per item)
RxCUI 402014
UNII KG60484QX9
UPC 0369230318355
Application # ANDA211732
SPL Set ID 9c856d3a-e38f-4006-a43a-ec1a9fa0f057
Established class (EPC) Proton Pump Inhibitor
Mechanism of action Proton Pump Inhibitors; Cytochrome P450 2C19 Inhibitors
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2020-03-25
Route ORAL
Dosage form TABLET, DELAYED RELEASE
Substance OMEPRAZOLE
GPI-14 49270060100620
GPI class Omeprazole Magnesium
GCN Seq No 025703
GCN 08454
HICL code 011115
Ingredient (HICL) Omeprazole Magnesium
HIC1 code D
Therapeutic class — broad (HIC1) Biliary System/Gastro-Intestinal System
HIC2 code D4
Therapeutic class — intermediate (HIC2) Drugs Acting Principally On The Alimentary Tract
HIC3 code D4J
Therapeutic class — specific (HIC3) Proton-Pump Inhibitors
AHFS code 56:28.36.00
AHFS class Proton-Pump Inhibitors
FDB label name OMEPRAZOLE MAG DR 20 MG TABLET
FDB brand name Omeprazole Magnesium
Legend status O — Over-the-counter (OTC) drug or device
Why two NDCs? The FDA registers this code as 69230-318-35 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 69230-0318-35. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏷️ RxNorm drug class

This medicine belongs to the Proton Pump Inhibitor class.

Pharmacologic class Proton Pump Inhibitor
Drug family (ATC) Proton pump inhibitors
How it works Proton Pump Inhibitors, Cytochrome P450 2C19 Inhibitors
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

🏭 Manufacturer & labeler

LabelerCamber Consumer Care Inc
Application holderHETERO LABS LTD UNIT III
FDA applicationANDA211732 (ANDA)
Labeler code69230
First marketedMar 2020
Product typeHuman Otc Drug
Portfolio18 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

Label name OMEPRAZOLE MAG DR 20 MG TABLET Ingredient Omeprazole Magnesium
📖 What it is MedlinePlus · NLM

Prescription omeprazole is used alone or with other medications to treat the symptoms of gastroesophageal reflux disease (GERD), a condition in which backward flow of acid from the stomach causes heartburn and possible injury of the esophagus (the tube between the throat and stomach) in adults and children 1 year of age and older. Prescription omeprazole is used to treat damage from GERD in adults and children 1 month of age and older. Prescription omeprazole is used to allow the esophagus to heal and prevent further damage to the esophagus in adults and children 1 year of age and older with G...

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • Omeprazole turns down your stomach's acid production by blocking the pump that makes acid in the first place. Depending on why you're taking it, that can mean relief from heartburn...
  • What exactly is omeprazole supposed to do for me?
  • Take it about 30 minutes before a meal, ideally before breakfast. Taking it before eating gives it the best chance to be absorbed and ready to work when your stomach starts produci...
  • When should I take it — before or after eating?
📖 Read our full Omeprazole guide →
9
Nutrient depletion considerations

Omeprazole may be associated with lower levels of 9 nutrients — worth a chat with your pharmacist, not a cause for alarm.

🧪 Full Omeprazole nutrient depletion report →
An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

💊 What it looks like

Color pink
ShapeOval
ImprintH;O9
Size14 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII OP1R32D61U
    Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
  • UNII 68401960MK
    Crospovidone is a synthetic polymer made from polyvinylpyrrolidone. It acts as a disintegrant, helping tablets break apart quickly in the stomach so the medicine dissolves and absorbs into the body.
  • UNII 1K09F3G675
    Ferric oxide red is an inorganic iron compound used as a colorant in medicines. It gives tablets, capsules, or other dosage forms a red or reddish tint for identification and appearance.
  • UNII 230OU9XXE4
    A waxy substance made from glycerin and stearic acid that acts as an emulsifier to blend oily and watery ingredients together. It also helps thicken and stabilize the medicine's texture.
  • UNII RFW2ET671P
    Hydroxypropyl cellulose is a plant-derived thickening agent made from cellulose. It acts as a binder to hold tablet ingredients together and as a film-former to coat tablets or control how fast the medicine releases.
  • UNII R75537T0T4
    Hypromellose 2910 is a plant-derived thickening agent made from cellulose. It serves as a binder that holds tablet ingredients together, a film-coating for pills, and a viscosity controller in liquids.
  • UNII EWQ57Q8I5X
    Lactose monohydrate is a natural sugar derived from milk. It serves as a filler and binder in tablets and capsules, helping create the proper size, texture, and consistency of the medicine.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII NX76LV5T8J
    A synthetic plastic polymer made from methacrylic acid and ethyl acrylate. It's used as a coating or binder to control how and where the medicine dissolves in your digestive system.
  • UNII 30IQX730WE
    Polyethylene glycol 6000 is a synthetic polymer made from ethylene glycol units. It acts as a binder, filler, and solubilizer in medicines to help hold ingredients together, add bulk, and improve how well active drugs dissolve and absorb.
  • UNII 6OZP39ZG8H
    Polysorbate 80 is a synthetic emulsifier derived from sorbitol and oleic acid. It helps mix oil and water-based ingredients together in medications and improves how the product disperses in the body.
  • UNII ETJ7Z6XBU4
    Silicon dioxide is a naturally occurring mineral used as a glidant and anti-caking agent. It helps powder ingredients flow smoothly and prevents clumping during manufacturing and storage.
  • UNII 55X04QC32I
    A strong alkaline chemical used to adjust and maintain the pH balance of liquid medicines. It helps keep the medicine stable and ensures it stays effective during storage.
  • UNII 368GB5141J
    A detergent and foaming agent derived from coconut or palm oil. In medications, it helps break down and mix oil and water-based ingredients, aids in tablet disintegration, and improves how the drug dissolves and spreads in the mouth or digestive system.
  • UNII O8232NY3SJ
    A plant-based carbohydrate derived from corn kernels. It acts as a filler to add bulk, a binder to hold ingredients together, and a disintegrant to help the tablet break apart in your stomach for absorption.
  • UNII C151H8M554
    A natural sugar derived from sugar cane or sugar beets. It's used as a sweetener, filler, and binder to improve taste, add bulk, and help hold tablet or capsule ingredients together.
  • UNII 7SEV7J4R1U
    A powder made from a naturally occurring mineral. In medicines, talc works as a glidant and anti-caking agent, helping tablets and capsules flow smoothly during manufacturing and preventing clumping.
  • UNII 15FIX9V2JP
    Titanium dioxide is a bright white mineral powder commonly used as a colorant and opacifying agent. It makes pills and tablets white or lighter in color and helps make coatings non-transparent.
  • UNII 8Z96QXD6UM
    Triethyl citrate is a clear liquid derived from citric acid. It acts as a plasticizer and solvent in tablet coatings and film formulations, helping the coating remain flexible and adhere properly to the medicine.

19 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statescolloidal silicon dioxide, crospovidone, glyceryl monostearate, hypromellose, hydroxypropyl cellulose, iron oxide red, magnesium stearate, methacrylic acid copolymer, polyethylene glycol, polysorbate 80, silicified microcrystalline cellulose, sodium hydroxide, sodium lauryl sulphate, starlac (contains lactose monohydrate and corn starch), sugar spheres (contains sucrose and corn starch), talc, titanium dioxide, triethyl citrate.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.473 $6.62 / 14 tablets
Medicaid paysCMS SDUD · 12 mo $0.6190 $8.67 / 14 tablets
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per ea) — tap or hover for the price & month
Jan 2022 Aug 2022 Jan 2026 Sep 2026 $0.506 $0.374
▲ Up 2% over the last 24 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Acid Reducer 20 mg 70000-0521-01 Cardinal 14 tablets $0.383 — FDA listed save 19%
rugby omeprazole 20 mg 00536-1448-13 Rugby 14 tablets $0.383 — Availability likely save 19%
omeprazole 20 mg 45802-0888-30 Padagis 1 tablet $0.383 — Availability likely save 19%
good neighbor pharmacy omeprazole 20 mg 46122-0029-03 Amerisource 1 tablet $0.383 — Availability likely save 19%
good neighbor pharmacy omeprazole 20 mg 46122-0281-04 Amerisource 14 tablets $0.383 — Availability likely save 19%
Omeprazole 20 mg 46122-0739-03 AMERISOURCEBERGEN 14 tablets $0.383 — Discontinued save 19%
Omeprazole 20 mg 51660-0029-14 OHM 14 tablets $0.383 — Availability likely save 19%
Omeprazole 20 mg 68001-0441-39 BluePoint 14 tablets $0.383 — Availability likely save 19%
leader omeprazole 20 mg 70000-0723-01 Cardinal 14 tablets $0.383 — Availability likely save 19%
Omeprazole 20 mg 70677-1098-01 STRATEGIC 14 tablets $0.383 — Availability likely save 19%
foster and thrive omeprazole 20 mg 70677-1104-01 Strategic 1 tablet $0.383 — Availability likely save 19%
foster and thrive omeprazole 20 mg 70677-1275-01 Strategic 14 tablets $0.383 — Availability likely save 19%
Omeprazole 20 mg 70677-0148-01 Strategic 14 tablets $0.424 — FDA listed save 10%
Omeprazole 20 mg 83324-0011-14 CHAIN 14 tablets $0.459 — Availability likely save 3%
Acid Reducer 20 mg 00536-1322-13 Rugby 14 tablets $0.473 — Availability likely —
Omeprazole 20 mgthis 69230-0318-35 Camber 14 tablets $0.473 — Availability likely —
Good Sense Omeprazole 20 mg 00113-0915-03 L. 14 tablets — — FDA listed —
Good Sense Omeprazole 20 mg 00113-1723-01 L. 14 tablets — — FDA listed —
good sense omeprazole delayed release 20 mg 00113-1803-03 L. 14 tablets — — FDA listed —
omeprazole 20 mg 00363-0007-01 Walgreen 14 tablets — — FDA listed —
omeprazole 20 mg 00363-0915-01 Walgreen 14 tablets — — FDA listed —
Acid Reducer 20 mg 00363-1008-05 WALGREEN 14 tablets — — FDA listed —
Omeprazole 20 mg 00363-1607-14 Walgreens 14 tablets — — FDA listed —
omeprazole 20 mg 00363-6101-03 Walgreen 14 tablets — — FDA listed —
Omeprazole 20.6 mg 00363-9510-14 Walgreens 14 tablets — — FDA listed —
Acid Reducer 20 mg 10202-0722-05 7-Eleven 14 tablets — — FDA listed —
up and up omeprazole 20 mg 11673-0018-01 Target 14 tablets — — FDA listed —
up and up omeprazole 20 mg 11673-0346-03 Target 14 tablets — — FDA listed —
up and up omeprazole 20 mg 11673-0915-01 Target 14 tablets — — FDA listed —
omeprazole 20 mg 11822-0453-01 Rite 14 tablets — — Discontinued —
omeprazole 20 mg 11822-0915-04 Rite 14 tablets — — Discontinued —
omeprazole 20 mg 11822-1190-01 Rite 14 tablets — — FDA listed —
Omeprazole 20 mg 21130-0018-14 Albertsons 14 tablets — — Discontinued —
Signature Care Omeprazole 20 mg 21130-0137-30 Safeway 1 tablet — — Discontinued —
signature care omeprazole 20 mg 21130-0401-01 Safeway 14 tablets — — FDA listed —
Omeprazole 20 mg 21130-0991-28 Living 14 tablets — — FDA listed —
Omeprazole 20 mg 25000-0091-76 MARKSANS 14 tablets — — FDA listed —
Acid Reducer 20 mg 30142-0077-01 KROGER 14 tablets — — FDA listed —
omeprazole 20 mg 30142-0474-01 Kroger 14 tablets — — FDA listed —
omeprazole 20 mg 30142-0557-01 Kroger 14 tablets — — FDA listed —
Omeprazole 20 mg 30142-0593-01 Kroger 14 tablets — — FDA listed —
omeprazole 20 mg 30142-0992-14 THE 14 tablets — — FDA listed —
TopCare Omeprazole delayed release 20 mg 36800-0121-01 Topco 14 tablets — — FDA listed —
TopCare Omeprazole 20 mg 36800-0915-01 Topco 14 tablets — — FDA listed —
Prilosec OTC 20.6 mg 37000-0455-01 The 1 tablet — — FDA listed —
Prilosec OTC 20 mg 37000-0459-01 The 1 tablet — — FDA listed —
omeprazole 20 mg 37808-0401-01 H 14 tablets — — FDA listed —
omeprazole 20 mg 37808-0915-01 H 14 tablets — — FDA listed —
Omeprazole 20 mg 37835-0001-42 BI-MART 14 tablets — — FDA listed —
Acid Reducer 20 mg 37835-0189-14 Bi-Mart 14 tablets — — FDA listed —
equaline omeprazole 20 mg 41163-0915-01 United 14 tablets — — FDA listed —
omeprazole 20 mg 41250-0401-01 Meijer 14 tablets — — FDA listed —
omeprazole 20 mg 41250-0915-01 Meijer 14 tablets — — FDA listed —
careone omeprazole 20 mg 41520-0802-03 American 14 tablets — — FDA listed —
care one omeprazole 20 mg 41520-0915-03 American 14 tablets — — FDA listed —
omeprazole 20 mg 42507-0414-01 HyVee 14 tablets — — FDA listed —
omeprazole 20 mg 42507-0915-01 HyVee 14 tablets — — FDA listed —
Omeprazole 20 mg 43598-0286-25 Dr. 14 tablets — — FDA listed —
Omeprazole 20 mg 43598-0841-42 Dr. 14 tablets — — FDA listed —
equate omeprazole 20 mg 49035-0119-01 Wal-Mart 14 tablets — — FDA listed —
Equate omeprazole delayed release acid reducer 20 mg 49035-0915-01 Wal-Mart 14 tablets — — FDA listed —
Acid Reducer 20 mg 49035-0983-62 Wal-Mart 14 tablets — — FDA listed —
Omeprazole delayed release 20 mg 49483-0731-41 TIME 14 tablets — — FDA listed —
Omeprazole 20 mg 50090-6888-00 A-S 14 tablets — — FDA listed —
Acid Reducer 20 mg 53943-0016-05 DISCOUNT 14 tablets — — FDA listed —
exchange select omeprazole 20 mg 55301-0915-55 Army 1 tablet — — FDA listed —
Acid Reducer 20 mg 55315-0996-04 Fred's, 14 tablets — — FDA listed —
Acid Reducer 20 mg 55319-0037-05 Family 14 tablets — — FDA listed —
Omeprazole 20.6 mg 55319-0219-14 Family 14 tablets — — FDA listed —
Omeprazole 20 mg 55681-0306-14 Twin 14 tablets — — FDA listed —
dg health omeprazole 20 mg 55910-0215-01 Dolgencorp 14 tablets — — FDA listed —
dg health omeprazole 20 mg 55910-0712-01 Dolgencorp 14 tablets — — FDA listed —
dg health omeprazole 20 mg 55910-0915-02 Dolgencorp, 14 tablets — — FDA listed —
omeprazole 20 mg 56062-0401-01 Publix 14 tablets — — FDA listed —
omeprazole 20 mg 56062-0915-30 Publix 1 tablet — — FDA listed —
Acid Reducer 20 mg 57483-0120-42 INNOVUS 14 tablets — — FDA listed —
omeprazole 20 mg 57483-0840-42 INNOVUS 14 tablets — — FDA listed —
Omeprazole 20 mg 57896-0659-42 GERI-CARE 14 tablets — — FDA listed —
Acid Reducer 20 mg 58602-0729-01 Aurohealth 14 tablets — — FDA listed —
Acid Reducer 20 mg 58602-0826-05 Aurohealth 14 tablets — — FDA listed —
Acid Reducer 20 mg 58602-0850-05 Aurohealth 14 tablets — — FDA listed —
omeprazole 20 mg 59640-0047-03 H 14 tablets — — FDA listed —
Omeprazole 20.6 mg 59726-0298-14 P 14 tablets — — FDA listed —
Omeprazole 20 mg 59726-0740-42 P 14 tablets — — FDA listed —
Omeprazole 20 mg 59726-0744-42 P 14 tablets — — FDA listed —
omeprazole 20 mg 59779-0503-01 CVS 14 tablets — — FDA listed —
Omeprazole 20 mg 59779-0580-01 CVS 14 tablets — — FDA listed —
Omeprazole 20 mg 62756-0377-11 Sun 14 tablets — — FDA listed —
Omeprazole 20.6 mg 63548-2970-02 PLD 42 tablets — — FDA listed —
Omeprazole 20.6 mg 63548-4080-02 PLD 1 tablet — — FDA listed —
Omeprazole 20.6 mg 63548-7370-02 PLD 42 tablets — — FDA listed —
Omeprazole 20.6 mg 63548-8040-02 PLD 1 tablet — — FDA listed —
Omeprazole 20 mg 63868-0471-14 Chain 14 tablets — — Discontinued —
Acid Reducer 20 mg 63941-0006-05 Best 14 tablets — — FDA listed —
Omeprazole 20 mg 63941-0997-14 VALU 14 tablets — — FDA listed —
kirkland signature omeprazole 20 mg 63981-0915-55 Costco 1 tablet — — FDA listed —
Omeprazole, 24/7 Life by 7-Eleven 20.6 mg 66715-6550-04 Lil' 14 tablets — — FDA listed —
Acid Reducer 20 mg 67091-0316-14 Winco 14 tablets — — FDA listed —
Omeprazole 20.6 mg 67091-0464-14 WinCo 14 tablets — — FDA listed —
Omeprazole 20 mg 67296-2183-08 Redpharm 14 tablets — — FDA listed —
members mark omeprazole 20 mg 68196-0700-01 Sam's 14 tablets — — FDA listed —
members mark omeprazole 20 mg 68196-0915-01 Sam's 14 tablets — — Discontinued —
Berkley and Jensen Omeprazole 20 mg 68391-0915-55 BJWC 1 tablet — — FDA listed —
Omeprazole 20 mg 69168-0476-14 Allegiant 14 tablets — — FDA listed —
Acid Reducer 20 mg 69618-0054-42 RELIABLE 14 tablets — — FDA listed —
Omeprazole 20 mg 69842-0661-01 CVS 14 tablets — — FDA listed —
Omeprazole 20 mg 72036-0981-14 HARRIS 14 tablets — — FDA listed —
basic care omeprazole 20 mg 72288-0047-01 Amazon.com 14 tablets — — FDA listed —
basic care omeprazole 20 mg 72288-0401-01 Amazon.com 14 tablets — — FDA listed —
Amazon Basic Care Omeprazole 20 mg 72288-0409-01 Amazon.com 14 tablets — — FDA listed —
basic care omeprazole 20 mg 72288-0915-01 Amazon.com 14 tablets — — FDA listed —
careone omeprazole 20 mg 72476-0473-01 Retail 14 tablets — — FDA listed —
omeprazole 20 mg 72559-0014-06 Little 14 tablets — — FDA listed —
topcare omeprazole 20 mg 76162-0470-01 Topco 14 tablets — — FDA listed —
24 hr omeprazole 20 mg 79481-0075-01 Meijer, 14 tablets — — FDA listed —
equate omeprazole 20 mg 79903-0113-14 WALMART 14 tablets — — FDA listed —
Omeprazole 20 mg 79903-0305-28 Walmart 14 tablets — — FDA listed —
Omeprazole 20.6 mg 79903-0377-14 WALMART 14 tablets — — FDA listed —
Acid Reducer 20 mg 80136-0852-03 NORTHEAST 14 tablets — — FDA listed —
good now omeprazole 20 mg 82501-0915-00 Gobrands, 1 tablet — — FDA listed —
Omeprazole 20 mg 83324-0141-14 Chain 14 tablets — — FDA listed —
Prilosec OTC 20.6 mg 84126-0300-14 The 14 tablets — — FDA listed —
Prilosec OTC 20.6 mg 84126-0301-14 The 14 tablets — — FDA listed —
24 HOUR Omeprazole 20 mg 85828-0731-45 Grocery 14 tablets — — FDA listed —
Omeprazole 20 mg 53943-0038-14 Discount 14 tablets — — FDA listed —
Omeprazole 20 mg 72288-0934-01 Amazon.com 14 tablets — — FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

⏳ Availability & generic status

🏛️
2020
On the market since
Mar 2020
📍
2026
Currently FDA-listed
6 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

🗺️ Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for 69230-0318-35, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
751
Units reimbursed last 4 qtrs
26.8K
Gross reimbursed last 4 qtrs
$16.6K
Avg / prescription
$22.09
Avg / unit
$0.6190
Latest quarter Q1 2026
224Rx
Medicaid pays / ea
$0.6190
gross reimbursed
vs
NADAC / ea
$0.4731
acquisition cost
=
Spread
+$0.1459
+31% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
30% FFS 70% MCO
Fee-for-service · 226 Rx Managed care · 525 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: no data reported MN Wisconsin: no data reported WI Michigan: no data reported MI New York: 983 units · 5.0 per 100k residents NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: 4,318 units · 102 per 100k residents OR Nevada: no data reported NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: no data reported IL Indiana: no data reported IN Ohio: 8,542 units · 72.5 per 100k residents OH Pennsylvania: no data reported PA New Jersey: no data reported NJ Massachusetts: no data reported MA California: 8,962 units · 23.0 per 100k residents CA Utah: no data reported UT Colorado: no data reported CO Nebraska: no data reported NE Missouri: no data reported MO Kentucky: no data reported KY West Virginia: no data reported WV Virginia: 2,019 units · 23.2 per 100k residents VA Maryland: 1,977 units · 32.0 per 100k residents MD Connecticut: no data reported CT Rhode Island: no data reported RI Arizona: no data reported AZ New Mexico: no data reported NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: no data reported SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: no data reported GA D.C.: no data reported DC Hawaii: no data reported HI Texas: no data reported TX Florida: no data reported FL
Units reimbursed · per 100k residents
5.0102
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Oregon 102 /100k
2 Ohio 72.5 /100k
3 Maryland 32.0 /100k
4 Virginia 23.2 /100k
5 California 23.0 /100k
6 New York 5.0 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

💊 Medicaid utilization by pack size

Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
14 tablets69230-0318-37 2,015 Rx · $47,140
14 tablets69230-0318-36 1,478 Rx · $29,203
14 tablets this page69230-0318-35 751 Rx · $16,589
500 tablets69230-0318-05 No Medicaid data
1000 tablets69230-0318-10 No Medicaid data
14 tablets69230-0318-32 No Medicaid data
14 tablets69230-0318-33 No Medicaid data
14 tablets69230-0318-34 No Medicaid data
Drug total (last 4 qtrs): 4,244 Rx · 154,646 units · $92,931 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.

📊 Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Omeprazole — the program that covers self-administered drugs. 14 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Omeprazole. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$75.01M
Claims incl. refills
7.1M
Beneficiaries
5.3M
Spend / beneficiary
$14.18
Spend / claim
$10.59
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

🔬 Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Omeprazole — the ingredient across all brands.

Top reported reactions

Chronic Kidney Disease36,807
Nausea27,095
Fatigue26,259
Diarrhoea25,668
Acute Kidney Injury23,964
Dyspnoea21,145
Pain20,498

Age at onset

Neonate292
Infant271
Child706
Adolescent877
Adult32,838
Elderly30,558

Reporter sex

448,293 reports
Male · 40%
Female · 60%
Unknown · 0%

Serious outcomes

Hospitalization150,621
Death39,276
Life-threatening19,121
Disabling14,768
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 45,465 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

📦 Packaging — all sizes for this product

Package NDCDescription Per unit Per pack Marketing startStatus
69230-0318-05 500 TABLET, DELAYED RELEASE in 1 BOTTLE (69230-318-05) — — 2020-10-29 Active
69230-0318-10 1000 TABLET, DELAYED RELEASE in 1 BOTTLE (69230-318-10) — — 2020-10-29 Active
69230-0318-32 1 BLISTER PACK in 1 CARTON (69230-318-32) / 14 TABLET, DELAYED RELEASE in 1 BLISTER PACK — — 2020-03-25 Active
69230-0318-33 2 BLISTER PACK in 1 CARTON (69230-318-33) / 14 TABLET, DELAYED RELEASE in 1 BLISTER PACK — — 2020-03-25 Active
69230-0318-34 3 BLISTER PACK in 1 CARTON (69230-318-34) / 14 TABLET, DELAYED RELEASE in 1 BLISTER PACK — — 2020-03-25 Active
69230-0318-35 You're viewing this 1 BOTTLE in 1 CARTON (69230-318-35) / 14 TABLET, DELAYED RELEASE in 1 BOTTLE $0.4731 / ea $6.62 2020-03-25 Active
69230-0318-36 2 BOTTLE in 1 CARTON (69230-318-36) / 14 TABLET, DELAYED RELEASE in 1 BOTTLE $0.4731 / ea $13.25 2020-03-25 Active
69230-0318-37 3 BOTTLE in 1 CARTON (69230-318-37) / 14 TABLET, DELAYED RELEASE in 1 BOTTLE $0.4731 / ea $19.87 2020-03-25 Active

This pack has the lowest per-ea cost of the 3 priced pack sizes ($0.4731 NADAC).

This pack accounts for about 18% of this product's recent Medicaid fills; the largest share goes to a different pack size. See all packs ↓

Pack size FAQ

What quantity is in NDC 69230-0318-35?
NDC 69230-0318-35 is a 14-count package — 1 bottle in 1 carton / 14 tablet, delayed release in 1 bottle.
What is the difference between NDC 69230-0318-35 and NDC 69230-0318-32?
Both are Omeprazole 20 mg Tablet, Delayed Release — the drug itself is identical. NDC 69230-0318-35 is the 14-count package, while NDC 69230-0318-32 is the 14 tablets package.
What NDC number is used to bill for this package of Omeprazole 20 mg Tablet, Delayed Release?
Bill NDC 69230-0318-35 — the 11-digit billing format is 69230031835. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose
🎯 Indications and Usage 31 words ▾

Use • treats frequent heartburn (occurs 2 or more days a week) • not intended for immediate relief of heartburn; this drug may take 1 to 4 days for full effect

⏱️ Dosage and Administration 153 words ▾

Directions • for adults 18 years of age and older • this product is to be used once a day (every 24 hours), every day for 14 days • it may take 1 to 4 days for full effect; some people get complete relief of symptoms within 24 hours 14-Day Course of Treatment • swallow 1 tablet with a glass of water before eating in the morning • take every day for 14 days • do not take more than 14 days unless directed by your doctor • swallow whole. Do not chew or crush tablets. Repeated 14-Day Courses (if needed) • you may repeat a 14-day course every 4 months • do not take for more than 14 days or more often than every 4 months unless directed by a doctor • children under 18 years of age: ask a doctor.

Heartburn in children may sometimes be caused by a serious condition.

⚠️ Warnings 42 words ▾

Warnings Allergy alert: Do not use if you are allergic to omeprazole. • Omeprazole may cause severe skin reactions. Symptoms may include: • skin reddening • blisters • rash If an allergy reaction occurs, stop use and seek medical help right away.

🧪 Active Ingredient 17 words ▾

Active ingredient (in each tablet) Omeprazole delayed-release tablet, 20 mg (equivalent to 20.6 mg omeprazole magnesium USP)

🧪 Inactive Ingredients 50 words ▾

Inactive ingredients colloidal silicon dioxide, crospovidone, glyceryl monostearate, hypromellose, hydroxypropyl cellulose, iron oxide red, magnesium stearate, methacrylic acid copolymer, polyethylene glycol, polysorbate 80, silicified microcrystalline cellulose, sodium hydroxide, sodium lauryl sulphate, starlac (contains lactose monohydrate and corn starch), sugar spheres (contains sucrose and corn starch), talc, titanium dioxide, triethyl citrate.

🎯 Purpose 3 words ▾

Purpose Acid reducer

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
← 69230-0316-11 · Camber 69230-0320-31 · Camber →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.